Monoclonal antibodies in oncology /
Monoclonal antibodies (mAbs) have been developed to improve the treatment outcome of cancer patients undergoing therapy according to multimodality regimens without a significant increase of treatment-associated toxicity. This five-chapter book provides examples where mAbs that have become part of th...
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
London, England :
Future Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK),
©2013.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Monoclonal antibodies in contemporary cancer therapy / Fatih M. Uckun
- mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment / Letizia Polito, Rossella Mancuso, Daniele Mercatelli, Massimo Bortolotti & Andrea Bolognesi
- mAbs targeting CTLA-4 and clinical outcomes / Francesco Spagnolo, Virginia Picasso & Paola Queirolo
- mAbs targeting VEGF/VEGFR and clinical outcomes in cancer treatment / Brendan Curley, Michael Newton & Jame Abraham
- mAbs targeting RANKL in bone metastasis treatment / Bérengère Gobin, Marc Baud'Huin, Bertrand Isidor, Dominique Heymann & Marie-Françoise Heymann
- Novel mAb-based therapies for leukemia / Osmond J. D'Cruz & Fatih M. Uckun
- Index.